Kanter, J., Walters, M. C., Krishnamurti, L., Mapara, M. Y., Kwiatkowski, J. L., Rifkin-Zenenberg, S., Aygun, B., Kasow, K. A., Pierciey, F. J., Bonner, M., Miller, A., Zhang, X., Lynch, J., Kim, D., Ribeil, J.-A., Asmal, M., Goyal, S., Thompson, A. A., & Tisdale, J. F. (2022). Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease. New England Journal of Medicine, 386(7), 617–628. https://doi.org/10.1056/nejmoa2117175
Subjects:
Genetic and Clinical Aspects of Hemoglobin Disorders
(OpenAlex Topic)
Regulation of Iron Metabolism and Anemia
(OpenAlex Topic)
Diseases Related to Blood Group Variants
(OpenAlex Topic)
Anemia, Sickle Cell
(MeSH)
Genetic Therapy
(MeSH)
Genetic Vectors
(MeSH)
Hemoglobins
(MeSH)
Lentivirus
(MeSH)
Stem Cell Transplantation
(MeSH)
beta-Globins
(MeSH)
Publication Type:
Article
Unique ID:
10.1056/NEJMoa2117175
PMID:
Journal:
Publication Date:
Data Source:
Scopus